14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 4.370 13 days ( -0.756 % )
Last Price $4.00 0.88 %
High/ Low $3.89 - $4.18 8.56%
Chg 7 Days N/A $4.00 $4.00
Chg 30 Days 1,424.97 % $0.262 $4.00
Chg 12 mos 464.97 % $0.708 $4.00
Trend - 3 mos 626.73 % Width: 322.37 %
Trend - 12 mos 12.96 % Width: 1,867.79 %
Pred. range - 3 mos $7.29 - $30.78 82.20 % - 669.55 %
Pred. range - 12 mos $0.230 - $4.53 -94.25 % - 13.17 %
Short MA avg 3 mos Buy Apr 25, 2024 - 7 days
Long MA avg 3 mos Buy Apr 15, 2024 - 15 days
Short/Long MA avg 3 mos Buy Apr 15, 2024 - 15 days
Short MA avg 12 mos Buy Apr 15, 2024 - 15 days
Long MA avg 12 mos Buy Apr 15, 2024 - 15 days
Short/Long MA avg 12 mos Buy Apr 15, 2024 - 15 days
Pivot Short Sell Apr 29, 2024 - 5 days
Bollinger Buy Mar 13, 2024 - 37 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About NuCana plc

NuCana plc NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase Ib clinical trials for the treatment of patients with biliary trac... NCNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT